Skip to main content

Advertisement

SpringerLink
Log in

Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Serum Epstein-Barr virus DNA has been approved for diagnosing nasopharyngeal carcinoma (NPC). The goal of this meta-analysis was to evaluate the clinical value of the serum Epstein-Barr virus DNA in the diagnosis of NPC. The PubMed, Embase, Web of Knowledge, Chinese Wanfang Med Online, and National Knowledge Infrastructure (CNKI) databases were searched to identify suitable studies. The pooled sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR−), and diagnostic odds ratio (DOR) of the serum Epstein-Barr virus DNA for the diagnosis of NPC were calculated. Summary receiver operating characteristic curves were used to summarize overall test performances. Meta-Disc 1.4 and Stata 12.0 softwares were used to analyze the data. A total of 2,520 patients from ten trials were subjected to meta-analysis. The summary estimates of the serum Epstein-Barr virus DNA for NPC diagnosis were as follows: sensitivity 0.69 (95 % confidence interval (CI) 0.65–0.72), specificity 0.84 (95 % CI = 0.82–0.86), LR + 4.81 (95 % CI = 2.94–7.88), LR − 0.25 (95 % CI = 0.13–0.48), DOR 24.65 (95 % CI = 12.64–48.07), and area under the summary receiver operator characteristic (SROC) curve (AUC) was 0.8979. Our study demonstrates that the serum Epstein-Barr virus DNA could be a useful tumor marker for NPC diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  CAS  PubMed  Google Scholar 

  2. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer. 1987;39:25–9.

    Article  CAS  PubMed  Google Scholar 

  4. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2002;2:9.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol. 2006;6:31.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein–Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res. 1998;4:665–9.

    CAS  PubMed  Google Scholar 

  9. Shotelersuk K, Khorprasert C, Sakdikul S, et al. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res. 2000;6:1046–51.

    CAS  PubMed  Google Scholar 

  10. Chan KH, Gu YL, Ng F, et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003;105:706–9.

    Article  CAS  PubMed  Google Scholar 

  11. Fan H, Nicholls J, Chua D, et al. Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus. Int J Cancer. 2004;112:1036–41.

    Article  CAS  PubMed  Google Scholar 

  12. Krishna SM, James S, Kattoor J, et al. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin. Jpn J Clin Oncol. 2004;34:307–11.

    Article  PubMed  Google Scholar 

  13. Luo YL, Ou GP, Chi PD, et al. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma. Chin J China. 2009;28:96–9.

    CAS  Google Scholar 

  14. Mo WN, Tang AZ, Zhou L, et al. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+/CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Chin Med J (Engl). 2009;122:1173–8.

    CAS  Google Scholar 

  15. Tan YJ, Su XK, Cui JH. Comparison of detection of serum VCA-lgA, EA-IgA and EBV-DNA in nasopharyngeal carcinoma patient. Chongqing Med J. 2010;39:703–6.

    CAS  Google Scholar 

  16. Wei K, Xu Y, Liu J, Zhang W, Liang Z. No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007. Asian Pac J Cancer Prev. 2010;11:1595–9.

    PubMed  Google Scholar 

  17. Zhang LW, Luo BQ, Dou XQ, et al. Quantitative analysis of Epstein-Barr virus DNA in saliva, blood serum and peripheral blood cells in patients with nasopharyngeal carcinoma. Chin J Otorhinolaryngol Skull Base Surg. 2012;18:24–7.

    CAS  Google Scholar 

  18. Rosenfeld RM, Shiffman RN. Clinical practice guidelines: a manual for developing evidence-based guidelines to facilitate performance measurement and quality improvement. Otolaryngol Head Neck Surg. 2006;135:S1–28.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Linyi City People’s Hospital, Linyi, 276000, China

    Dezhong Sun, Zhaoke Yang, Yugui Fu, Yanlin Chen & Yanyi Ma

  2. Department of Medicine Oncology, Linyi City People’s Hospital, Linyi, 276000, China

    Shoufeng Wang, Yun Zhang & Xiaoyan Zhang

Authors
  1. Dezhong Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhaoke Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yugui Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanlin Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoufeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yanyi Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiaoyan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaoyan Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, D., Yang, Z., Fu, Y. et al. Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma. Tumor Biol. 35, 8787–8793 (2014). https://doi.org/10.1007/s13277-014-2148-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2148-x

Keywords

Search

Navigation